The proposed study seeks to evaluate pain tolerance and analgesic response in drug abusers receiving opiate maintenance treatment, a population for which pain management is a frequent and clinically challenging issue. Although overlap between brain systems responsible for both pain and opiate dependence is increasingly appreciated, little is known about the experience of pain for persons chronically ingesting exogenous opiates. Thus we propose to describe pain tolerance in opiate-maintained individuals and evaluate their response to analgesic medications. A methadone-maintained (n = 54), a buprenorphine-maintained (n = 54) and a LAAM-maintained (n = 54) sample will be recruited, and their tolerance to a standardized cold-pressor test (CPT) will be evaluated upon admission to treatment and again once they have stabilized on opiate maintenance to learn if and how pain tolerance changes over the course of opiate maintenance treatment. The CPT analgesic response of these stabilized subjects will be evaluated by double blind administration of oral opiate (Dilaudid, 3 mg.), non-opiate (Toradol, 10 mg.), and placebo using a Latin square design, and compared to that noted in a sample of matched controls. Proposed analyses will provide information on 1) pain tolerance for treatment-seeking opiate addicts, 2) pain tolerance for three opiate- maintained samples, 3) analgesic agents which are effective for opiate- maintained persons, and 4) potential differences in pain response between persons maintained on methadone, buprenorphine and LAAM. It is anticipated that the findings from the proposed study will have important clinical implications for the assessment and treatment of pain in this population which is prone to painful morbidity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA009260-05
Application #
6270034
Study Section
Project Start
1998-09-15
Project End
2001-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Friends Research Institute, Inc.
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Miotto, Karen; Hillhouse, Maureen; Donovick, Roger et al. (2012) Comparison of buprenorphine treatment for opioid dependence in 3 settings. J Addict Med 6:68-76
Ling, Walter; Cunningham-Rathner, Jerry; Rawson, Richard (2004) Diffusion of substance abuse treatment: will buprenorphine be a success? J Psychoactive Drugs Suppl 2:115-7
Ling, Walter; Wesson, Donald R (2003) Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend 70:S49-57
Lopatko, Olga V; White, Jason M; Huber, Alice et al. (2003) Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine. Drug Alcohol Depend 69:317-22
Ling, Walter; Rawson, Richard A; Compton, Margaret (2003) Clinical treatment of opioid addiction and dependence. Methods Mol Med 84:285-95
Doverty, M; White, J M; Somogyi, A A et al. (2001) Hyperalgesic responses in methadone maintenance patients. Pain 90:91-6
Doverty, M; Somogyi, A A; White, J M et al. (2001) Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 93:155-63
Kirkish, P; Sreenivasan, S; Welsh, R et al. (2000) The future of criminal violence: juveniles tried as adults. J Am Acad Psychiatry Law 28:38-46
Ling, W; Shoptaw, S; Majewska, D (1998) Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 18:403-4
Frosch, D L; Shoptaw, S; Jarvik, M E et al. (1998) Interest in smoking cessation among methadone maintained outpatients. J Addict Dis 17:9-19

Showing the most recent 10 out of 12 publications